Monitoring chronic headache and medication-overuse headache prevalence in Denmark
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Objectives: To study chronic headache and medication-overuse headache (MOH) prevalence; to identify groups with high prevalence of these conditions; and to identify the most frequently used pain medications among respondents with chronic headache. Background: Chronic headache and MOH prevalence in Denmark were last estimated in 2010. Methods: In this cross-sectional study, 104,950 individuals aged ≥16 years were randomly sampled for the 2017 Danish Capital Region Health Survey. Responses to questions about headache and use of acute pain medications were linked to demographic registries. MOH was defined as headache ≥15 days/month plus self-report of use of pain medications ≥10 or 15 days/month, in the last three months. Weighted prevalence proportions were calculated. Results: Among 55,185 respondents, chronic headache prevalence was 3.0% (95% CI: 2.3–3.2) and MOH prevalence was 2.0% (95% CI: 1.8–2.1). Both conditions were more common among females and the middle-aged. Respondents on social welfare or receiving early retirement pensions had the highest prevalences. Among those with chronic headache, 44.7% overused over-the-counter analgesics for headache; paracetamol 41.5%; a combination of different pain relievers 25.3%; ibuprofen 21.9%; opioids 17.0%; combination preparations 14.3%; and triptans 9.1%. Conclusions: The highest prevalence of chronic headache and MOH was seen among people with low socioeconomic position. Overuse of paracetamol was most common. Reported opioid use was higher than expected. Groups with high prevalence of MOH should be the focus of public health interventions on rational use of OTC and prescription pain medications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632 · cited 2×
“Researchers did not have access to the reference database containing individual identities (39,40).”
BackgroundMethodIndicators of socioeconomic position (part 1): Figure 1
Galobardes, B., Shaw, M., Lawlor, D. A., Lynch, J. W., & Davey Smith, G. (2006) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2004.023531 · Cited by 2,867 · cited 1×
“Socioeconomic position (SEP) is a term that describes social and economic factors that ‘‘influence what positions individuals or groups hold within the structure of a society’’ and describes a range of ‘‘exposures, resources, and susceptibilities that may affect health’’ (42).”
BackgroundThe Danish National Prescription Registry
Wallach Kildemoes, H., Toft Sørensen, H., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,467
Stovner, L. J., Nichols, E., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., Ansha, M. G., Barac, A., Bensenor, I. M., Doan, L. P., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30322-3 · Cited by 1,908
Measuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818 · cited 2×
“The Global Burden of Disease (GBD) studies show that headaches are among the top causes of disability, calculated from an estimate of degree of disability, and years of life lived with short- or long-term health loss (1,2).”
BackgroundThygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum-Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,084 · cited 2×
“These 12-digit numbers were used consistently to link data from the DK-CRHS to national registers with information on age, sex, ethnicity, educational attainment, work status, and income (40).”
BackgroundMethod
Research works printed but not linked: 3
- Mbewe E, 2015, J Headache Pain, 16, 515
- Dansk Hovedpine Selskab. Referenceprogram: Diagnostik og behandling af hovedpinesygdomme og ansigtssmerter, 2. udgave [Guidelines: Diagnosis and treatment of headache disorders and facial pain, 2nd edition]. Copenhagen: Dansk Hovedpine Selskab, 2010.
- Fangel S, 2007, Metode og Data, 93, 14
Cited by
Ashina, S., Terwindt, G. M., Steiner, T. J., Lee, M. J., Porreca, F., Tassorelli, C., Schwedt, T. J., Jensen, R. H., Diener, H.-C., & Lipton, R. B. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00415-0 · Cited by 213
Self-citationZobdeh, F., Kraiem, A. B., Attwood, M. M., Chubarev, V. N., Tarasov, V. V., Schiöth, H. B., & Mwinyi, J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15657 · Cited by 158
“A recent epidemiological populationbased study in Denmark reported a prevalence of 2% in 55,000 respondents (Westergaard et al., 2020).”
BackgroundKatsuki, M., Yamagishi, C., Matsumori, Y., Koh, A., Kawamura, S., Kashiwagi, K., Kito, T., Entani, A., Yamamoto, T., Ikeda, T., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-021-05831-w · Cited by 61
Evidence-based guidelines for the pharmacological treatment of migraine
Ornello, R., Caponnetto, V., Ahmed, F., Al‐Khazali, H. M., Ambrosini, A., Ashina, S., Baraldi, C., Bellotti, A., Brighina, F., Calabresi, P., et al. (2025) · Cephalalgia · doi:10.1177/03331024241305381 · Cited by 97
The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update
Sun‐Edelstein, C., Rapoport, A. M., Rattanawong, W., & Srikiatkhachorn, A. (2021) · CNS Drugs · doi:10.1007/s40263-021-00818-9 · Cited by 49
Metadata
- Authors
- Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T., & Jensen, R. H.
- Affiliations
- Glostrup Hospital (DK)
- Frederiksberg Hospital (DK)
- Corresponding author
- Westergaard, Maria Lurenda
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2019-09-15
- Volume
- 40
- Issue
- 1
- Pages
- 6-18
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2974896636
- Cited by
- 44
- References
- 57
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 1
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Cephalalgia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- TrygFonden
- Allergan
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- chronic headache, medication overuse headache, prevalence, over-the-counter analgesics, paracetamol, opioid use, triptans, socioeconomic position, welfare recipients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Denmark, Female, Health Surveys, Humans, Male, Middle Aged, Risk Factors, Prevalence, Headache Disorders, Headache Disorders, Secondary, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monitoring chronic headache and medication-overuse headache prevalence in Denmark. https://app.cochat.ai/papers/10.1177/0333102419876909
- The paper
- Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T., & Jensen, R. H. (2020). Monitoring chronic headache and medication-overuse headache prevalence in Denmark. Cephalalgia. https://doi.org/10.1177/0333102419876909
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.